BMRA stock forecast
Our latest prediction for Biomerica, Inc.'s stock price was made on the Feb. 9, 2018 when the stock price was at 3.90$.
In the short term (2weeks), BMRA's stock price should outperform the market by 2.59%. During that period the price should oscillate between -8.54% and +12.99%.
In the medium term (3months), BMRA's stock price should outperform the market by 2.27%. During that period the price should oscillate between -19.34% and +35.20%.Get email alerts
About Biomerica, Inc.
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.
At the moment the company generates 5M USD in revenues.
On its last earning announcement, the company reported a loss of -0.20$ per share.
The book value per share is 0.48$
Three months stock forecastFeb. 9, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|